Chemours Co (CC)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands -237,000 -316,000 -88,000 489,000 578,000 908,000 882,000 747,000 609,000 395,000 257,000 215,000 219,000 -117,000 -117,000 -45,000 -51,000 408,000 607,000 792,000
Total stockholders’ equity US$ in thousands 737,000 755,000 808,000 1,227,000 1,107,000 1,284,000 1,214,000 1,166,000 1,081,000 998,000 898,000 850,000 813,000 732,000 657,000 655,000 689,000 837,000 823,000 810,000
ROE -32.16% -41.85% -10.89% 39.85% 52.21% 70.72% 72.65% 64.07% 56.34% 39.58% 28.62% 25.29% 26.94% -15.98% -17.81% -6.87% -7.40% 48.75% 73.75% 97.78%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-237,000K ÷ $737,000K
= -32.16%

The return on equity (ROE) of Chemours Co has varied significantly over the past few quarters. The ROE was negative in recent quarters, with values of -32.16% in December 2023 and -41.85% in September 2023, indicating that the company had a net loss relative to its shareholders' equity during these periods.

However, the ROE rebounded in the earlier quarters, with a peak ROE of 97.78% in March 2019. This high ROE suggests that the company was efficient in generating profits from the shareholders' equity during that period.

Overall, there seems to be volatility in Chemours Co's ROE performance, with fluctuations between negative and positive values. It is essential for stakeholders to monitor the company's profitability and financial health closely, considering the significant variations in ROE.